University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Resource Types

Rapid Advice: Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants

Get This Resource

English: Web Page

Summary

Since the 2006 WHO recommendations on PMTCT, several clinical trials have shown the efficacy of ARVs in preventing transmission to the infant while breastfeeding. The 2009 recommendations promote the use of ARVs earlier in pregnancy, starting at 14 weeks and continuing through the end of the breastfeeding period. WHO now recommends that breastfeeding continue until the infant is 12 months of age, provided the HIV-positive mother or baby is taking ARVs during that period. This will reduce the risk of HIV transmission and improve the infant's chance of survival.

Related Resources

Publisher: World Health Organization
Language: English
Format: Web Page
Region: Global
Audiences: Doctors/Physicians, Physician's Assistants/Nurse Practitioners, Policymakers
Topic Areas: Perinatal Interventions, Antiretroviral Treatment & Complications, General Care during Pregnancy, Labor, & Delivery
Resource Type: Clinical Guidelines